Folks,
Let's assume we are looking at a potential LBO target. The target is a SaaS platform. They capitalize 30% of their R&D expenses. When modeling the case, would you adjust EBITDA/EBIT for the capitalized R&D (and the respective amortization) or not? Why?
Looking forward to the discussion.
| +92 | Mid Level Career Freeze | 27 | 12h |
| +42 | Clearlake raises a $14.8B fund | 28 | 1d |
| +28 | Left PE for an operating role and starting to regret it | 6 | 15h |
| +24 | Working on Juneteenth | 11 | 11h |
| +24 | From Public Equities to Private Equities | 4 | 21h |
| +20 | PE Portfolio Management/Ops - pros and cons | 1 | 4d |
| +20 | Late night thoughts as I spread comps….. | 5 | 2h |
| +19 | Best Path to PE from BB Coverage w/ Outsourced Modeling | 7 | 3d |
| +16 | Becoming a great VC/PE investor - advice | 4 | 2d |
| +12 | LMM groups within larger platforms? | 1 | 1d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Harum omnis dolorum eaque. Ea cupiditate amet nemo voluptatibus. Dignissimos rerum fuga nihil blanditiis aut veniam. Et eaque et iure.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...